170410 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Skeletal Muscle-On-A-Chip In Microgravity As A Platform For Regeneration Modeling And Drug Screening
#2CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION
#3BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO CANCER IMMUNOTHERAPEUTIC AGENT AND USE THEREOF
#4DETECTION METHOD OF CIRCULATING BMP10 (BONE MORPHOGENETIC PROTEIN 10)
#5REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT DISEASES
#6OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF
#7METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS
#8BIOMARKERS FOR PREDICTING IMMINENT OVULATION OR REPRODUCTIVE COMPETENCE IN MARES
#9METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#10Antibodies and Immunoassays for Detection of BMP-15 and GDF-9 Isoforms
#11Compositions and methods for modulating left-right differentiation factor (LEFTY) and bone morphogenic factor (BMP)
#12TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#13Cardiovascular Risk Event Prediction and Uses Thereof
#14Compositions and methods for programmable sensing and control through combinatorial molecular interactions
#15Cantilever sensors for molecule detection
#16BIOMARKER FOR USE IN TREATING ANEMIA
#17Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
#18Methods for the diagnosis and treatment of Sjögren's syndrome
#19TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#20METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE
#21Methods for identifying, diagnosing, and predicting survival of lymphomas
#22Cantilever sensors for molecule detection
#23Process and compositions for achieving mammalian energy balance
#24AGENTS, METHODS AND KITS FOR TREATING AND DETECTING DIABETIC NEPHROPATHY AND PROLIFERATIVE DISEASES AND METHODS FOR INHIBITING EXPRESSION OF TYPE IV COLLAGEN
#25Compositions and methods for increasing bone mineralization
#26STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#27METHODS FOR PREDICTING AMOUNTS OF OSTEOACTIVITY MARKERS
#28BIOMARKER FOR USE IN TREATING ANEMIA
#29Methods for the diagnosis and treatment of sjögren's syndrome
#30Cardiovascular Risk Event Prediction and Uses Thereof
#31Retrieval of biological materials from the human uterus, ovary and cervix by suction
#32Compositions and Methods of Detecting and Treating Neural Tube Defects
#33Method for screening for a therapeutic agent for idiopathic interstitial pneumonia
#34Cardiovascular Risk Event Prediction and Uses Thereof
#35Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#36Polynucleotides encoding antibodies against sclerostin and uses therefor
#37METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS
#38Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
#39Compositions and Methods to Treat Bone Related Disorders
#40Monoclonal antibody and use thereof
#41Compositions and Methods for Increasing Bone Mineralization
#42NOVEL TISSUE CULTURE PLATFORM FOR SCREENING OF POTENTIAL BONE REMODELING AGENTS
#43Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4
#44Method for detection of idiopathic interstitial pneumonia
#45SCREENING METHODS FOR BONE MORPHOGENETIC MIMETICS
#46Methods for Diagnosing and Treating Iron Dysregulation
#47Compositions and methods for use for antibodies against sclerostin
#48Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins
#49NELL-1 ENHANCED BONE MINERALIZATION
#50METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION
#51PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY
#52Methods to increase or decrease bone density
#53Assessment of physiological conditions
#54METHODS FOR DETECTING NEUTRALIZING ANTIBODIES FOR BONE MORPHOGENETIC PROTEINS
#55Method of treating glaucoma comprising administering a composition comprising human BMP7
#56Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1
#57Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
#58Monoclonal antibody and use thereof
#59METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE CELL SIGNALING AND METHODS EMPLOYING SUCH COMPOUNDS
#60Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#61ASSESSING MAMMALS FOR VASCULAR DISEASES AND VALVULAR DISEASES
#62Compositions and methods for bone formation, bone remodeling and toxin protection
#63Compositions and Methods to Treat Bone Related Disorders
#64Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4
#65Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#66NOVEL METHOD OF MODULATING BONE-RELATED ACTIVITY
#67Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#68HBM variants that modulate bone mass and lipid levels
#69Compositions and methods for use for antibodies against sclerostin
#70Screening method for bone morphogenetic mimetics
#71Nell-1 enhanced bone mineralization
#72BMP-3 antibodies and related methods
#73Compositions and methods for increasing bone mineralization
#74Methods to increase or decrease bone density
#75Methods of Using Bone Morphogenic Proteins as Biomarkers for Determining Cartilage Degeneration and Aging
#76Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin
#77Compositions and methods for increasing bone mineralization
#78Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or α1 type IV collagen
#79METHOD AND COMPOSITION FOR ENHANCING BONE FORMATION
#80Cd4+ epitopes of bone morphogenetic proteins
#81GDF-9/BMP-15 modulators for the treatment of bone disorders
#82Systems and methods for screening for modulators of neural differentiation
#83Insulin-Independent, Bone Morphogenetic Protein (Bmp)-Mediated Uptake Of Blood Glucose By Peripheral Cells And Tissues
#84Materials and methods for identifying agents that modulate Norrin, Norrin mimetics, and agents identified thereby
#85Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#86Methods and kits using a molecular interaction between a Smurf-1 WW domain and LIM mineralization protein isoforms
#87Systems and methods for screening for modulators of neural differentiation
#88Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts
#89Methods for identifying, diagnosing, and predicting survival of lymphomas
#90Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging
#91NELL-1 enhanced bone mineralization
#92Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#93Osteogenesis-promotion enhancer and method of screening the same
#94Nell-1 enhanced bone mineralization
#95Methods to diagnose and treat lung cancer
#96Methods and compositions to promote bone homestasis
#97Methods and compositions to promote bone homeostasis
#98BMP-3 propeptides and related methods
#99Novel method of modulating bone-related activity
#100High-yield extraction of osteoinductive agents from DBM and methods for measuring the same
#101Bone morphogenic proteins (bmp),bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
#102HBM variants that modulate bone mass and lipid levels